Skip to main content

Table 2 Endpoint events in the study cohort at 30 days

From: Comparison of the prognosis for different onset stage of cardiogenic shock secondary to ST-segment elevation myocardial infarction

Events

Non-CS (n = 562)

CS on admission (n = 32)

Developed CS (n = 81)

p-value

All cause death, n (%)

13(2)

1(3)

2(2)

0.956

MACE

 Cardiac death, n (%)

13(2)

1(3)

2(2)

0.956

 Angina/Recurrent MI, n (%)

4(1)

0(0)

0(0)

0.667

 Worsening of cardiac function, n (%)

2(0)

1(3)

1(1)

0.101

 Non-fatal stroke, n (%)

0(0)

1(3)

0(0)

P < 0.001

  1. MI Myocardial infarction, MACE Major adverse cardiac events